Market Access France ‘first EU country to cover obesity drugs’ PharmaphorumFrance's Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies.Metabolic & GLP-1Read full story pharminent May 28, 2026 (Last updated: May 29, 2026) Pharmaphorum France’s Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies. Metabolic & GLP-1 Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: GSK hails ‘unprecedented’ cure rates with hep B drugNext: CVS obesity drug deal puts Lilly on equal footing with Novo Related Stories Market Access pharminent June 12, 2026 Market Access Aquipta recommended by NICE for acute migraine treatment pharminent June 10, 2026 Market Access AbbVie’s migraine drug cleared for migraine attacks on NHS pharminent June 10, 2026
